{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:30:46Z","timestamp":1792798246605,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":3571,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Canadian Hemophilia Society Research Grant","id":[{"id":"https:\/\/ror.org\/0216whp02","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1111\/jth.12130","type":"journal-article","created":{"date-parts":[[2013,1,11]],"date-time":"2013-01-11T08:30:37Z","timestamp":1357893037000},"page":"512-520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles"],"prefix":"10.1016","volume":"11","author":[{"given":"M.","family":"Bowman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Notley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tinlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Deforest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Leggo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VS.","family":"Blanchette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lillicrap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12130_bb0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12130_bb0015","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/beha.2001.0139","article-title":"Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology","volume":"14","author":"Eikenboom","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1111\/jth.12130_bb0020","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1538-7836.2006.02070.x","article-title":"Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study","volume":"4","author":"Castaman","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12130_bb0025","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1111\/j.1538-7836.2006.02158.x","article-title":"When it comes to von Willebrand disease, does 1\u00a0+\u00a01\u00a0=\u00a03?","volume":"4","author":"Montgomery","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12130_bb0030","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1160\/TH06-07-0383","article-title":"An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease","volume":"96","author":"Cumming","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12130_bb0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the european study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.12130_bb0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105","article-title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.12130_bb0045","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1182\/blood.V75.3.654.654","article-title":"Severe type III von Willebrand's disease caused by deletion of exon 42 of the von willebrand factor gene: family studies that identify carriers of the condition and a compound heterozygous individual","volume":"75","author":"Peake","year":"1990","journal-title":"Blood"},{"key":"10.1111\/jth.12130_bb0050","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-0038-1648835","article-title":"Characterization of partial gene deletions in type III von Willebrand disease with alloantibody inhibitors","volume":"72","author":"Mancuso","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12130_bb0055","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1079-9796(03)00033-0","article-title":"Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients","volume":"30","author":"Baronciani","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"10.1111\/jth.12130_bb0060","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bcmd.2006.03.003","article-title":"A novel Alu-mediated 61-kb deletion of the von Willebrand factor (VWF) gene whose breakpoints co-locate with putative matrix attachment regions","volume":"36","author":"Xie","year":"2006","journal-title":"Blood Cells Mol Dis"},{"key":"10.1111\/jth.12130_bb0065","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/j.1538-7836.2008.03107.x","article-title":"An Alu-mediated novel large deletion is the most frequent cause of type 3 von Willebrand disease in Hungary","volume":"6","author":"Mohl","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12130_bb0070","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood-2008-08-173278","article-title":"A novel deletion mutation is recurrent in von Willebrand disease types 1 and 3","volume":"114","author":"Sutherland","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.12130_bb0075","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI112974","article-title":"Gene deletions correlate with the development of alloantibodies in von Willebrand disease","volume":"79","author":"Shelton-Inloes","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12130_bb0080","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1073\/pnas.85.8.2753","article-title":"Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease","volume":"85","author":"Ngo","year":"1988","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1111\/jth.12130_bb0085","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/BF00206958","article-title":"Genetic heterogeneity of severe von Willebrand disease type III in the German population","volume":"94","author":"Schneppenheim","year":"1994","journal-title":"Hum Genet"},{"key":"10.1111\/jth.12130_bb0090","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1055\/s-0037-1615050","article-title":"Characterization of the genetic defects in recessive type 1 and type 3 von Willebrand disease patients of Italian origin","volume":"79","author":"Eikenboom","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12130_bb0095","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1365-2516.2009.02078.x","article-title":"Multiplex ligation-dependent probe amplification to detect a large deletion within the von Willebrand gene","volume":"15","author":"Acquila","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12130_bb0100","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2141.2010.08400.x","article-title":"First application of MLPA method in severe von Willebrand disease. confirmation of a new large VWF gene deletion and identification of heterozygous carriers","volume":"152","author":"Cabrera","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12130_bb0105","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1538-7836.2011.04260.x","article-title":"Large deletions identified in patients with von Willebrand disease using multiple ligation-dependent probe amplification","volume":"9","author":"Yadegari","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12130_bb0110","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/geno.1994.1241","article-title":"Characterization of the von Willebrand factor gene (VWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish origin","volume":"21","author":"Zhang","year":"1994","journal-title":"Genomics"},{"key":"10.1111\/jth.12130_bb0115","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1365-2516.2009.02059.x","article-title":"The mutation spectrum associated with type 3 von Willebrand disease in a cohort of patients from the north west of England","volume":"15","author":"Sutherland","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12130_bb0120","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1538-7836.2011.04250.x","article-title":"Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population","volume":"9","author":"Mohl","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12130_bb0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bcmd.2008.03.004","article-title":"Genetic defects in von Willebrand disease type 3 in Indian and Greek patients","volume":"41","author":"Gupta","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"10.1111\/jth.12130_bb0130","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/j.1538-7836.2008.03182.x","article-title":"Generation and validation of the condensed MCMDM-1VWD bleeding questionnaire for von Willebrand disease","volume":"6","author":"Bowman","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12130_bb0135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-4613-0331-2_7","article-title":"Antibodies to von Willebrand factor in von Willebrand disease","volume":"386","author":"Mannucci","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"10.1111\/jth.12130_bb0140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ajcp\/109.3.347","article-title":"The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications","volume":"109","author":"Casonato","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/jth.12130_bb0145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0037-1613768","article-title":"Collagen binding assay for von Willebrand factor (VWF:CBA): detection of von Willebrand disease (VWD) and discrimination of VWD subtypes, depends on collagen source","volume":"83","author":"Favaloro","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12130_bb0150","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1093\/nar\/19.19.5444","article-title":"A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies","volume":"19","author":"Lahiri","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.1111\/jth.12130_bb0155","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1365-2516.2009.02046.x","article-title":"Molecular characterization of Iranian patients with type 3 von Willebrand disease","volume":"15","author":"Shahbazi","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12130_bb0160","doi-asserted-by":"crossref","first-page":"7937","DOI":"10.1073\/pnas.90.17.7937","article-title":"Mutations of von Willebrand factor gene in families with von Willebrand disease in the \u00c5land Islands","volume":"90","author":"Zhang","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/jth.12130_bb0165","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1182\/blood.V96.2.560.014k01_560_568","article-title":"A novel von Willebrand disease-causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion","volume":"96","author":"Allen","year":"2000","journal-title":"Blood"},{"key":"10.1111\/jth.12130_bb0170","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1160\/TH08-08-0500","article-title":"Rapid molecular diagnosis of von Willebrand disease by direct sequencing","volume":"101","author":"Corrales","year":"2009","journal-title":"Thromb Haemos"},{"key":"10.1111\/jth.12130_bb0175","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1182\/blood.V98.1.248","article-title":"Homozygous gene conversion in von Willebrand factor gene as a cause of type 3 von Willebrand disease and predisposition to inhibitor development","volume":"98","author":"Surdhar","year":"2001","journal-title":"Blood"},{"key":"10.1111\/jth.12130_bb0180","first-page":"850","article-title":"Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I","volume":"51","author":"Zhang","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.1111\/jth.12130_bb0185","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.2006.06055.x","article-title":"Homozygous C2362F von Willebrand factor induces intracellular retention of mutant von Willebrand factor resulting in autosomal recessive severe von Willebrand disease","volume":"133","author":"Tjernberg","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12130_bb0190","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2516.2008.01682.x","article-title":"Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease","volume":"14","author":"Baronciani","year":"2008","journal-title":"Haemophilia"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12130","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12130","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622137827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622137827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12130\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:06:16Z","timestamp":1761534376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622137827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1538783622137827"],"URL":"https:\/\/doi.org\/10.1111\/jth.12130","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}